Last reviewed · How we verify
activated recombinant human factor VII — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
activated recombinant human factor VII (activated recombinant human factor VII) — Novo Nordisk A/S.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| activated recombinant human factor VII TARGET | activated recombinant human factor VII | Novo Nordisk A/S | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- activated recombinant human factor VII CI watch — RSS
- activated recombinant human factor VII CI watch — Atom
- activated recombinant human factor VII CI watch — JSON
- activated recombinant human factor VII alone — RSS
Cite this brief
Drug Landscape (2026). activated recombinant human factor VII — Competitive Intelligence Brief. https://druglandscape.com/ci/activated-recombinant-human-factor-vii. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing